Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Operating cash flow minus capital expenditures
Percentile
P86
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-180000.00 | +97.3% |
| 2024 | $-6.77M | -139.1% |
| 2023 | $17.31M | +204.7% |
| 2022 | $5.68M | +106.7% |
| 2021 | $-84.59M | -52.9% |
| 2020 | $-55.31M | -26.6% |
| 2019 | $-43.68M | -51.0% |
| 2018 | $-28.93M | -44.9% |
| 2017 | $-19.96M | -5.4% |
| 2016 | $-18.94M | - |